N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells

Development of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by N-myristoylation of AMPs CM4, had anticancer activity against MCF-7, MDA-MB-231, M...

Full description

Bibliographic Details
Main Authors: Caiyun Li, Hongyan Liu, Yunqing Yang, Xixi Xu, Tongtong Lv, Huidan Zhang, Kehang Liu, Shuangquan Zhang, Yuqing Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-11-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01297/full
_version_ 1818822168998313984
author Caiyun Li
Hongyan Liu
Yunqing Yang
Xixi Xu
Tongtong Lv
Huidan Zhang
Kehang Liu
Shuangquan Zhang
Yuqing Chen
author_facet Caiyun Li
Hongyan Liu
Yunqing Yang
Xixi Xu
Tongtong Lv
Huidan Zhang
Kehang Liu
Shuangquan Zhang
Yuqing Chen
author_sort Caiyun Li
collection DOAJ
description Development of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by N-myristoylation of AMPs CM4, had anticancer activity against MCF-7, MDA-MB-231, MX-1 breast cancer cells (IC50 of 3–6 μM) and MDA-MB-231 xenograft tumors. The improved activity was attributed to the effect of myristoyl on the cell membrane. Flow cytometry and confocal laser scanning microscopy results showed that N-myristoylation significantly increased the membrane affinity toward breast cancer cells and also effectively mediated cellular entry. Despite increasing cytotoxicity against HEK293 and NIH3T3 cells and erythrocytes associated with its anticancer activity, myristoyl-CM4 maintained a certain selectivity toward breast cancer cells. Accordingly, the membrane affinity toward breast cancer cells was two to threefold higher than that of normal cells. Glycosylation analysis showed that sialic acid-containing oligosaccharides (including O-mucin and gangliosides) were important targets for myristoyl-CM4 binding to breast cancer cells. After internalization, co-localization analysis revealed that myristoyl-CM4 targeted mitochondria and induced mitochondrial dysfunction, including alterations in mitochondrial transmembrane potential, reactive oxygen species (ROS) generation and cytochrome c release. Activation of caspase 9, caspase 3 and cleavage of PARP were observed in MX-1, MCF-7, and MDA-MB-231 cells after myristoyl-CM4 treatment. The current work indicates that increasing hydrophobicity by myristoylation to modulate peptide-membrane interactions and then target mitochondria is a good strategy to develop AMPs as anticancer agents in the future.
first_indexed 2024-12-18T23:19:48Z
format Article
id doaj.art-55776eef4d00482e827879940e3933e4
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-12-18T23:19:48Z
publishDate 2018-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-55776eef4d00482e827879940e3933e42022-12-21T20:48:01ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-11-01910.3389/fphar.2018.01297413527N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer CellsCaiyun LiHongyan LiuYunqing YangXixi XuTongtong LvHuidan ZhangKehang LiuShuangquan ZhangYuqing ChenDevelopment of antimicrobial peptides (AMPs) as highly effective and selective anticancer agents would represent great progress in cancer treatment. Here we show that myristoyl-CM4, a new synthetic analog generated by N-myristoylation of AMPs CM4, had anticancer activity against MCF-7, MDA-MB-231, MX-1 breast cancer cells (IC50 of 3–6 μM) and MDA-MB-231 xenograft tumors. The improved activity was attributed to the effect of myristoyl on the cell membrane. Flow cytometry and confocal laser scanning microscopy results showed that N-myristoylation significantly increased the membrane affinity toward breast cancer cells and also effectively mediated cellular entry. Despite increasing cytotoxicity against HEK293 and NIH3T3 cells and erythrocytes associated with its anticancer activity, myristoyl-CM4 maintained a certain selectivity toward breast cancer cells. Accordingly, the membrane affinity toward breast cancer cells was two to threefold higher than that of normal cells. Glycosylation analysis showed that sialic acid-containing oligosaccharides (including O-mucin and gangliosides) were important targets for myristoyl-CM4 binding to breast cancer cells. After internalization, co-localization analysis revealed that myristoyl-CM4 targeted mitochondria and induced mitochondrial dysfunction, including alterations in mitochondrial transmembrane potential, reactive oxygen species (ROS) generation and cytochrome c release. Activation of caspase 9, caspase 3 and cleavage of PARP were observed in MX-1, MCF-7, and MDA-MB-231 cells after myristoyl-CM4 treatment. The current work indicates that increasing hydrophobicity by myristoylation to modulate peptide-membrane interactions and then target mitochondria is a good strategy to develop AMPs as anticancer agents in the future.https://www.frontiersin.org/article/10.3389/fphar.2018.01297/fullantimicrobial peptides CM4myristoylationbreast cancermembranemitochondriaxenograft tumor
spellingShingle Caiyun Li
Hongyan Liu
Yunqing Yang
Xixi Xu
Tongtong Lv
Huidan Zhang
Kehang Liu
Shuangquan Zhang
Yuqing Chen
N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
Frontiers in Pharmacology
antimicrobial peptides CM4
myristoylation
breast cancer
membrane
mitochondria
xenograft tumor
title N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
title_full N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
title_fullStr N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
title_full_unstemmed N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
title_short N-myristoylation of Antimicrobial Peptide CM4 Enhances Its Anticancer Activity by Interacting With Cell Membrane and Targeting Mitochondria in Breast Cancer Cells
title_sort n myristoylation of antimicrobial peptide cm4 enhances its anticancer activity by interacting with cell membrane and targeting mitochondria in breast cancer cells
topic antimicrobial peptides CM4
myristoylation
breast cancer
membrane
mitochondria
xenograft tumor
url https://www.frontiersin.org/article/10.3389/fphar.2018.01297/full
work_keys_str_mv AT caiyunli nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT hongyanliu nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT yunqingyang nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT xixixu nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT tongtonglv nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT huidanzhang nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT kehangliu nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT shuangquanzhang nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells
AT yuqingchen nmyristoylationofantimicrobialpeptidecm4enhancesitsanticanceractivitybyinteractingwithcellmembraneandtargetingmitochondriainbreastcancercells